1,014
Views
1
CrossRef citations to date
0
Altmetric
Pharmacology & Pharmaceutics

Alteplase improves acute cerebral infarction by improving neurological function and cerebral hemodynamics

, , , , &
Pages 187-194 | Received 30 Oct 2020, Accepted 26 Feb 2021, Published online: 18 Mar 2021

References

  • Ansar S, Chatzikonstantinou E, Thiagarajah R, Tritschler L, Fatar M, Hennerici MG, Meairs S. 2014. Pro-inflammatory mediators and apoptosis correlate to rt-PA response in a novel mouse model of thromboembolic stroke. PloS one. 9(1):e85849.
  • Bong JB, Kang HG, Choo IS. 2017. Acute cerebral infarction after pyrethroid ingestion. Geriatr Gerontol Int. 3(17):510–511.
  • Brüning T, Al-Khaled M. 2015. Risk of symptomatic intracerebral hemorrhage after thrombolysis with rt-pa: the sedan score. CNS Neurosci Ther. 21(3):296.
  • Chen Y, Zhao Y. 2018. Curative efficacy of penehyclidine combined with edaravone on acute cerebral infarction and their effects on serum TNF-α and NDS score in rats. Eur Rev Med Pharmacol Sci. 22:223–228.
  • Choi J-I, Ha S-K, Lim D-J, Kim S-D, Kim S-H. 2018. S100ss, matrix metalloproteinase-9, D-dimer, and heat shock protein 70 are serologic biomarkers of acute cerebral infarction in a mouse model of transient MCA occlusion. J Korean Neurosurg Soc. 61(5):548.
  • Fugate JE, Rabinstein AA. 2015. Absolute and relative contraindications to IV rt-PA for acute ischemic stroke. Neurohospitalist. 5(3):110–121.
  • Gon Y, Sakaguchi M, Oyama N, Mochizuki H. 2017. Diagnostic utility of contrast-enhanced 3D T1-weighted imaging in acute cerebral infarction associated with graves disease. J Stroke Cerebrovasc Dis. 26(2):e38–e40.
  • He X, Li D, Cui C, Wen L. 2017. Clinical significance of serum MCP-1 and VE-cadherin levels in patients with acute cerebral infarction. Eur Rev Med Pharmacol Sci. 21(4):804–808.
  • Jia C, Wei C, Hu M, Xu J, Niu K, Zhang C, Lv P, Li L, Dong Y. 2018. Correlation between antiplatelet therapy in secondary prevention of acute cerebral infarction and cerebral microbleeds: a susceptibility-weighted imaging (SWI) study. J Xray Sci Technol. 26(4):623–633.
  • Ji B, Zhou F, Han L, Yang J, Fan H, Li S, Li J, Zhang X, Wang X, Chen X. 2017. Sodium tanshinone IIA sulfonate enhances effectiveness Rt-PA treatment in acute ischemic stroke patients associated with ameliorating blood-brain barrier damage. Transl Stroke Res. 8(4):334–340.
  • Lin Z-J, Qiu H-Y, Tong X-X, Guo Y, Han M-F, Yang C-S, Lin K-H, Wu J, Li X, Yang Y. 2018. Evaluation of efficacy and safety of reteplase and alteplase in the treatment of hyper-acute cerebral infarction. Biosci Rep. 38(1):BSR20170730.
  • Misumi I, Nagao A, Iwamoto K, Honda T, Ishii M, Ueyama H, Maeda Y, Ishizaki M, Kurisaki R, Okazaki T. 2017. Acute multiple cerebral infarction in a patient with an accessory mitral valve. Intern Med. 56(2):153–155.
  • Mould WA, Carhuapoma JR, Muschelli J, Lane K, Morgan TC, McBee NA, Bistran-Hall AJ, Ullman NL, Vespa P, Martin NA. 2013. Minimally invasive surgery plus rt-PA for intracerebral hemorrhage evacuation (MISTIE) decreases perihematomal edema. Stroke. 44(3):627.
  • Shinohara Y, Kato A, Kuya K, Okuda K, Sakamoto M, Kowa H, Ogawa T. 2017. Perfusion MR imaging using a 3D pulsed continuous arterial spin-labeling method for acute cerebral infarction classified as branch atheromatous disease involving the lenticulostriate artery territory. AJNR Am J Neuroradiol. 38(8):1550–1554.
  • Sobolewski P, Brola W, Wiszniewska M, Szczuchniak W, Fudala M, Domagalski M, Śledzińska-Dźwigał M. 2014. Intravenous thrombolysis with rt-PA for acute ischemic stroke within 24 h of a transient ischemic attack. J Neurol Sci. 340(1-2):44–49.
  • Song T-J, Chang Y, Chun M-Y, Lee C-Y, Kim A-R, Kim Y, Kim Y-J. 2018. High dietary glycemic load is associated with poor functional outcome in patients with acute cerebral infarction. J Clin Neurol. 14(2):165–173.
  • Sun X, Berthiller J, Trouillas P, Derex L, Diallo L, Hanss M. 2015a. Early fibrinogen degradation coagulopathy: a predictive factor of parenchymal hematomas in cerebral rt-PA thrombolysis. J Neurol Sci. 351(1-2):109–114.
  • Sun X, Berthiller J, Derex L, Trouillas P, Diallo L, Hanss M. 2015b. Post-thrombolysis haemostasis changes after rt-PA treatment in acute cerebral infarct. Correlations with cardioembolic aetiology and outcome. J Neurol Sci. 349(1-2):77–83.
  • Sun B, Li X, Liu X, Ge X, Lu Q, Zhao X, Pu J, Xu J, Zhao H. 2017. Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 16(1):111.
  • Tabata E, Yasaka M, Wakugawa Y, Okada Y. 2014. Recombinant tissue-type plasminogen activator (rt-PA) therapy in an acute stroke patient taking dabigatran etexilate: a case report and literature review. Intern Med. 53(14):1515–1517.
  • Tampieri A, Giovannini E, Rusconi AM, Cristoni L, Bendanti D, Cenni P, Lenzi T. 2015. Safety and feasibility of intravenous rt-PA in the emergency department without a neurologist-based stroke unit: an observational study. Intern Emerg Med. 10(2):181–192.
  • Tang S, Luo C, Zhang K, Li K, Fan X, Ning L, Xue P. 2017. Effects of dl-3-n-butylphthalide on serum VEGF and bFGF levels in acute cerebral infarction. Eur Rev Med Pharmacol Sci. 21(19):4431–4436.
  • Wan J-L, Ma Z-W. 2017. The value of mean platelet volume for prognosis of patients with acute cerebral infarction. Clin Lab. 63(11):1801–1807.
  • Xu X, Li C, Wan T, Gu X, Zhu W, Hao J, Bao H, Zuo L, Hu H, Li G. 2017. Risk factors for hemorrhagic transformation after intravenous thrombolysis in acute cerebral infarction: a retrospective single-center study. World Neurosurg. 101:155–160.
  • Xu W, Xie N, Zhang C, Huang Q. 2018. Imaging characteristics and pathogenesis of intracranial artery stenosis in patients with acute cerebral infarction. Exp Ther Med. 15(5):4564.
  • Zhang Y-Z, Wang J, Xu F. 2017. Circulating miR-29b and miR-424 as prognostic markers in patients with acute cerebral infarction. Clin Lab. 63(10):1667–1674.